GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles

被引:3
|
作者
Zhai, Xiang-Hong [1 ,2 ]
Zhang, Ping [2 ,3 ]
Wu, Feng-Xia [4 ]
Wang, An-Cong [2 ,3 ]
Liu, Pei-Shu [5 ]
机构
[1] Linyi Peoples Hosp, Dept Obstet & Gynecol, Linyi Hlth Sch, Linyi 276003, Shandong, Peoples R China
[2] Linyi Peoples Hosp, Dept Resp Med, 27 Jiefang Rd, Linyi 276003, Shandong, Peoples R China
[3] Linyi Peoples Hosp, Dept Obstet & Ginecol, Linyi 276003, Shandong, Peoples R China
[4] Shandong Univ, Dept Anat, Jinan 250012, Shandong, Peoples R China
[5] Shandong Univ, Qilu Hosp, Dept Obstet & Ginecol, Jinan 250012, Shandong, Peoples R China
关键词
polycystic ovary syndrome; in vitro fertilization and embryo transfer; gonadotrophin-releasing hormone antagonist; ovarian hyperstimulation syndrome; clinical pregnancy; fresh cycle; ENDOMETRIAL RECEPTIVITY; ANALOG; IVF; GONADOTROPINS; METAANALYSIS; THICKNESS;
D O I
10.3892/etm.2017.4309
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to evaluate the influence of a gonadotropin-releasing hormone (GnRH) antagonist compared with a GnRH agonist on the in vitro fertilization cycle outcome in patients with polycystic ovary syndrome. The outcomes of pregnancy were evaluated. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was also used to evaluate whether the endometrial thickness (cm) and estradiol (E-2) level (pg/ml) on the day of human chorionic gonadotropin (hCG) administration (the hCG day) had the best sensitivity and specificity for predicting a clinical pregnancy. The results demonstrated that there were significant differences in the E-2 and progesterone levels between the two treatment groups on the hCG day. Furthermore, the mean number of total oocytes retrieved, mean number of 2 pronuclei oocytes, mean number of oocytes cleaved (P< 0.05), mean number of embryos available (P= 0.022) and mean number of embryos transferred (P= 0.014) were significantly different. Additionally, the rates of ectopic pregnancy (P= 0.984) and ovarian hyperstimulation syndrome (P= 0.976) did not differ significantly between the treatment groups. Although the biochemical pregnancy (P= 0.592), clinical pregnancy (P= 0.617) and live birth (P= 0.365) rates were lower with the GnRH antagonist than with the GnRH agonist, there were no significant differences in the outcomes between the two groups. Analysis of the influence of endometrial thickness with respect to the clinical pregnancy using the ROC (AUC) method revealed that when the best cutoff of 9.75 cm was used, the sensitivity was 62.5%, the specificity was 43.1% and the AUC was 0.53. Additionally, the Youden index was 0.056. Analysis of the influence of the E-2 level on the hCG day on clinical pregnancy, using the ROC (AUC) method showed that the best cutoff was 2,984.5 pg/ml, which had a sensitivity of 68.8% and specificity of 52.9%, while the AUC was 0.573 (with a Youden index of 0.217). Furthermore, the results demonstrated that neither the endometrial thickness nor the E-2 level on the hCG day had the best sensitivity and specificity for predicting a clinical pregnancy.
引用
收藏
页码:3097 / 3102
页数:6
相关论文
共 50 条
  • [31] Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer
    Cha, KY
    Chung, HM
    Lee, DR
    Kwon, H
    Chung, MK
    Park, LS
    Choi, DH
    Yoon, TK
    FERTILITY AND STERILITY, 2005, 83 (05) : 1461 - 1465
  • [32] The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer
    Zhou, Jing-Shuang
    Chen, Jian-Hong
    Tang, Fei-Fei
    Ou, Jian-Ping
    Tao, Xin
    Cai, Liu-Hong
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [33] The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer
    Jing-Shuang Zhou
    Jian-Hong Chen
    Fei-Fei Tang
    Jian-Ping Ou
    Xin Tao
    Liu-Hong Cai
    BMC Pregnancy and Childbirth, 23
  • [34] Methylprednisolone for prevention of ovarian hyperstimulation syndrome in patients with polycystic ovarian syndrome undergoing in-vitro fertilisation: a randomised controlled trial
    Yeganeh, Ladan Mohammadi
    Moini, Ashraf
    Shiva, Marzieh
    Mirghavam, Naimeh
    Lankarani, Narges Bagheri
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 38 (02) : 241 - 246
  • [35] Cyst aspiration or GnRH antagonist administration for ovarian cysts detected at the start of fresh in vitro fertilization cycles
    Pereira, Nigel
    Amrane, Selma
    Hobeika, Elie
    Lekovich, Jovana P.
    Chung, Pak H.
    Rosenwaks, Zev
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (07) : 562 - 565
  • [36] In vitro fertilization and embryo transfer in seminatural cycles for patients with ovarian aging
    Branco, AC
    Achour-Frydnian, N
    Kadoch, J
    Fanchin, R
    Tachdjian, G
    Frydman, R
    FERTILITY AND STERILITY, 2005, 84 (04) : 875 - 880
  • [37] Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
    Kahnberg, Annika
    Enskog, Anders
    Brannstrom, Mats
    Lundin, Kersti
    Bergh, Christina
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) : 1373 - 1381
  • [38] Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer
    Check, JH
    Choe, JK
    Katsoff, D
    Summers-Chase, D
    Wilson, C
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1999, 16 (08) : 416 - 420
  • [39] Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection
    Ozmen, B.
    Sukur, Y. E.
    Seval, M. M.
    Ates, C.
    Atabekoglu, C. S.
    Sonmezer, M.
    Berker, B.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 183 : 137 - 140
  • [40] Impact of cryopreservation and subsequent embryo transfer on the outcome of in vitro fertilization in patients at high risk for ovarian hyperstimulation syndrome
    Wiener-Megnazi, Z
    Lahav-Baratz, S
    Rothschild, E
    Abramovici, H
    Dirnfeld, M
    FERTILITY AND STERILITY, 2002, 78 (01) : 201 - 203